# NX Pharmagen funding: rounds and investors > NX Pharmagen has raised $6.7M across 4 rounds since 2012. Investors include Keyhorse Capital. Every round with its source. Source: https://millionrounds.com/company/nx-pharmagen (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *NX Pharmagen* 4 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Funding summary Updated 26 Oct 2026 **$6.7M** raised across 4 rounds since 2012, from 4 sources **$3.5M** Seed **$773K** Debt **$1.8M** Venture **$590K** Debt - **Latest round:** Debt, $590K Oct 2022 - **Biggest round:** $3.5M Seed · Jan 2012 - **Investors:** 1 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2012 2014 2016 2018 2020 2022 **$3.5M** Seed **$773K** Debt **$1.8M** Venture **$590K** Debt - **First round:** Seed, $3.5M - **Biggest round:** $3.5M - **Usual gap between rounds:** 21 months ## The rounds - **Oct 2022** Debt **$590K** *1 new* [Keyhorse Capital](https://millionrounds.com/fund/keyhorse-capital) Source recorded SEC filing: $590K sold, first sale Oct 2022 - **Mar 2015** Venture **$1.8M** No investor was named in the report. From a historical funding record - **Jun 2013** Debt **$773K** No investor was named in the report. Reported by sec.gov SEC filing: $773K sold, first sale Jun 2013 - **Jan 2012** Seed **$3.5M** No investor was named in the report. From a historical funding record ## Founders and team From the SEC filings it signed: 1 on the team. - **Brian Brohman** Executive Officer, Director i On the board, as filed i *Alan Ezrin* *Robert Saunders* ## Everyone who backed them [Keyhorse Capital](https://millionrounds.com/fund/keyhorse-capital) VC firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=nx-pharmagen). ## Also claim to have backed them These 2 firms list NX Pharmagen as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [VisionTech Partners](https://millionrounds.com/fund/visiontech-partners-visiontech-angels) Angel network Per its own site [XLerateHealth](https://millionrounds.com/fund/xleratehealth) Accelerator Per its own site ## Quick answers about NX Pharmagen ### Who invested in NX Pharmagen? NX Pharmagen's investors include Keyhorse Capital. ### How much has NX Pharmagen raised? NX Pharmagen has raised $6.7M across 4 rounds since 2012. ### When did NX Pharmagen last raise? NX Pharmagen's most recent round was a Debt of $590K in Oct 2022. ### What was NX Pharmagen's biggest round? NX Pharmagen's largest round on record is $3.5M (Seed), in Jan 2012. ### Who backed NX Pharmagen first? NX Pharmagen's first round on record, in Oct 2022, was backed by Keyhorse Capital. ### What stage is NX Pharmagen at? NX Pharmagen's latest named round is a Debt, in Oct 2022. ### Where is NX Pharmagen based? NX Pharmagen is based in the United States. ## Companies like NX Pharmagen In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app